$0.7084
0.005000.71%
At close: -
$0.7050
-0.00340-0.48%
After Hours: Apr 25, 7:56 PM EDT
Comments
Loading...
Lexicon Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:LXRX | Benzinga
Lexicon Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$-0.100
Quarterly Revenue Estimate
$1.18M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$31.08M
Analyze the earnings history of Lexicon Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals | -$0.20 | -$0.10 | — | — | $1.13M | $1.18M | — | — | 05/09/2025 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.20 | -$0.12 | -$0.09 | 25.00% | $702.00K | $6.48M | $26.55M | 309.78% | 03/06/2025 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.21 | -$0.16 | -$0.18 | -12.50% | $162.00K | $2.93M | $1.75M | -40.27% | 11/12/2024 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.22 | -$0.19 | -$0.17 | 10.53% | $317.00K | $2.83M | $1.65M | -41.80% | 08/01/2024 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.17 | -$0.20 | -$0.20 | — | $24.00K | $1.37M | $1.13M | -17.52% | 05/02/2024 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.22 | -$0.20 | 9.09% | $28.00K | $1.24M | $702.00K | -43.39% | 03/11/2024 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.13 | -$0.21 | -$0.21 | 0.00% | $39.00K | $2.06M | $162.00K | -92.14% | 11/08/2023 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.17 | -$0.22 | -29.41% | $35.00K | $70.00K | $317.00K | 352.86% | 08/03/2023 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.18 | -$0.17 | 5.56% | $37.00K | $30.00K | $24.00K | -20.00% | 05/02/2023 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.17 | -$0.13 | -$0.16 | -23.08% | $14.00K | $50.00K | $28.00K | -44.00% | 03/02/2023 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.14 | -$0.13 | 7.14% | $23.00K | $50.00K | $39.00K | -22.00% | 11/09/2022 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.13 | -$0.16 | -$0.16 | 0.00% | $234.00K | $50.00K | $35.00K | -30.00% | 08/02/2022 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.15 | -$0.16 | -$0.16 | 0.00% | $27.00K | $50.00K | $37.00K | -26.00% | 05/05/2022 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.04 | -$0.18 | -$0.17 | 5.56% | $199.00K | — | $14.00K | — | 02/28/2022 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.43 | -$0.18 | -$0.16 | 11.11% | $6.63M | — | $23.00K | — | 11/03/2021 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.65 | -$0.16 | -$0.13 | 18.75% | $9.16M | $10.00K | $234.00K | 2240.00% | 07/30/2021 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.63 | -$0.16 | -$0.15 | 6.25% | $8.00M | $1.68M | $27.00K | -98.39% | 05/06/2021 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.48 | -$0.28 | -$0.04 | 85.71% | $8.73M | $110.00K | $199.00K | 80.91% | 03/10/2021 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.10 | $0.26 | -$0.43 | -265.38% | $294.45M | $16.87M | $6.63M | -60.68% | 10/29/2020 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.22 | -$0.61 | -$0.65 | -6.56% | $9.68M | $8.83M | $9.16M | 3.77% | 07/30/2020 | Get Alert |
| LXRX | Lexicon Pharmaceuticals | -$0.21 | -$0.69 | -$0.63 | 8.70% | $9.22M | $7.79M | $8.00M | 2.68% | 04/27/2020 | Get Alert |
Lexicon Pharmaceuticals (LXRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $-0.09 | $-0.12 | 25.0 % |
| Q3 | 2024-11-12 | $-0.18 | $-0.16 | -12.5 % |
| Q2 | 2024-08-01 | $-0.17 | $-0.19 | 10.5 % |
| Q4 | 2024-03-11 | $-0.20 | $-0.22 | 9.09 % |
Lexicon Pharmaceuticals (LXRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $26.55M | $6.48M | 309.8 % |
| Q3 | 2024-11-12 | $1.75M | $2.93M | -40.3 % |
| Q2 | 2024-08-01 | $1.65M | $2.83M | -41.8 % |
| Q1 | 2024-05-02 | $1.13M | $1.37M | -17.5 % |
FAQ
When is Lexicon Pharmaceuticals (NASDAQ:LXRX) reporting earnings?
Lexicon Pharmaceuticals (LXRX) is scheduled to report earnings on May 9, 2025. The last reported earnings were for reported on March 6, 2025 for Q4.
What were the latest earnings per share (EPS) for Lexicon Pharmaceuticals (NASDAQ:LXRX)?
The Actual EPS was $-0.09, which beat the estimate of $-0.12.
What were Lexicon Pharmaceuticals’s (NASDAQ:LXRX) revenues?
The Actual Revenue was $26.6M, which beat the estimate of $6.5M.
Browse earnings estimates, EPS, and revenue on all stocks.
